Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Apyx Medical (APYX) over the last 15 years, with Q3 2025 value amounting to $519000.0.

  • Apyx Medical's Capital Expenditures rose 23921.57% to $519000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 9017.54%. This contributed to the annual value of $722000.0 for FY2024, which is 3545.97% up from last year.
  • Latest data reveals that Apyx Medical reported Capital Expenditures of $519000.0 as of Q3 2025, which was up 23921.57% from $265000.0 recorded in Q2 2025.
  • In the past 5 years, Apyx Medical's Capital Expenditures ranged from a high of $519000.0 in Q3 2025 and a low of $29000.0 during Q2 2021
  • For the 5-year period, Apyx Medical's Capital Expenditures averaged around $201421.1, with its median value being $174000.0 (2023).
  • Within the past 5 years, the most significant YoY rise in Apyx Medical's Capital Expenditures was 178888.89% (2021), while the steepest drop was 6914.89% (2021).
  • Over the past 5 years, Apyx Medical's Capital Expenditures (Quarter) stood at $332000.0 in 2021, then plummeted by 57.23% to $142000.0 in 2022, then plummeted by 34.51% to $93000.0 in 2023, then surged by 163.44% to $245000.0 in 2024, then skyrocketed by 111.84% to $519000.0 in 2025.
  • Its Capital Expenditures stands at $519000.0 for Q3 2025, versus $265000.0 for Q2 2025 and $55000.0 for Q1 2025.